Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
暂无分享,去创建一个
A. Makris | G. Wilson | F. Daley | G. Wilson | P. Richman | F. Daley | P. Richman | S. Allen | R. Burcombe | M. Pittam | S. Allen | J. Dove | S. Noble | D. Wright